Program Length:
30 minutes
Resources:
PROGRAM HANDOUT AVAILABLE.
View the Program Materials tab to download.
Credits:
This program has CFPC Mainpro+® accreditation. See the Credit Eligibility tab for more information.
Target Audience:
Family physicians
Program Length:
30 minutes
Resources:
PROGRAM HANDOUT AVAILABLE.
View the Program Materials tab to download.
Credits:
This program has CFPC Mainpro+® accreditation. See the Credit Eligibility tab for more information.
Target Audience:
Family physicians
This program was developed by the Canadian Collaborative Research Network.
Program Description:
Inflammation is known to play an important role in the pathogenesis of atherosclerosis. Colchicine, an anti-inflammatory drug, has now been tested in several large trials of patients with coronary artery disease. While these trials have shown overall benefit on CV outcomes, there has been a trend towards increased non-CV death with colchicine. This podcast will explore the potential benefits of colchicine in CAD vs. the potential risks, and discuss whether colchicine should become a guideline-endorsed therapy for patients with CAD.
Learning Objectives
This 1-credit-per-hour Self-Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 0.5 Mainpro+® credits.
Download program handout:
This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization. No outside funding support was received for this program.